Facing challenges in aligning departmental goals and managing cold chain logistics, this pharmaceutical company struggled with overstocking and spoilage due to unreliable data and lack of real-time visibility. An end-to-end logistics visibility solution provided real-time condition monitoring, accurate ETAs, and improved departmental coordination, allowing the company to streamline operations and ensure the safe, on-time delivery of critical COVID-19 vaccines. This case study highlights the pivotal changes implemented to optimise supply chain efficiency and support the global distribution of life-saving vaccines.
To ensure patient safety, the pharma giant verified condition of stock at various points in the supply chain. However, lack of real-time supply and condition data led to overstocking to maximise inventory availability of saleable stock. They relied on their freight forwarders and carriers to learn about the Estimated Time of Arrival (ETA), which was often inaccurate, or the update was not actionable. They relied on data loggers for “on-arrival” condition verification.
In due course, they realised that their inventory challenge was induced by a larger problem: lack of alignment of department-specific goals with company goals.
1. Lack of Alignment of KPIs with Company Vision
Even before the pandemic, the company realised that although their two main departments — transportation and logistics — were delivering well on their respective objectives, they were not working in sync, which costed the company big.
For example, the transportation team would focus on cost reduction, while the logistics team wanted on-time in-full (OTIF) delivery. Many of their multimodal shipments which were going from Europe to the US or North America were moved by different modes — air or ocean, with a significant first and last mile segment on road. Since the transport team prioritised optimising cost, this parameter solely drove decisions on the freight forwarders and carriers used.
Multiple divisions supplying to consolidated warehouses meant there was no single visibility thread. Owing to this, the pharma company constantly endured fluctuating inventory or was overstocking more than it was required to ensure timely availability for its patients.
Both departments were trying to save costs, however, one wanted to achieve it by lowering transportation cost, while the other strived to achieve it by improving efficiency using premium modes of transport to bring predictability. Ultimately, they were both unable to meet their goals — they could neither run a lean and predictable inventory operation, nor save on transportation costs.
2. Lack of Condition Information until Arrival
Another big problem plaguing the pharma company in their cold chain logistics was — lack of accurate and timely data on shipment condition prior to arrival. There were many instances where the vaccines that were delivered had to be discarded because of spoilage. Although they had condition data, it was not useful because they would only find out about the excursions upon arrival, since they were using passive cold chain data loggers.
Upon arrival, some of the vaccines were found to have exceeded the Mean Kinetic Temperature, because of which they had to be discarded, causing a void in inventory. This led to problems like inventory gaps, overstocking, and locked up working capital, moving the logistics team’s target of lean inventory farther.
They Tried GPS Trackers, Visibility Platforms, and Data Loggers, but without Success
This company happens to be a large, global COVID-19 vaccine manufacturer. Improved end-to-end logistics visibility brought behavioral change for this pharma giant, which is all set to distribute coronavirus vaccines. Once the system was in place, the company could easily extend the solution to their COVID-19 vaccine shipments.
With the solution, the pharma company gained control over their logistics even without relying on the carrier or logistics provider for location and condition data. The rich insights that they got into the routes, lanes, and efficiency of transport providers enabled them to ensure that the COVID-19 vaccines were delivered intact and on time, with high confidence on their efficacy and stability.
The solution is also going to be a savior in their plan to ship vaccines outside of North America into developing parts of the world, which are not accustomed to first world cold chain management yet.
Boost your Supply Chain Quality Compliance